Jim Simons Atri Cure, Inc. Transaction History
Renaissance Technologies LLC
- $62.3 Billion
- Q1 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Atri Cure, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 307,900 shares of ATRC stock, worth $8.95 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
307,900
Previous 163,900
87.86%
Holding current value
$8.95 Million
Previous $5.01 Million
98.32%
% of portfolio
0.02%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
49MCall Options Held
25.8KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$137 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$134 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.84MShares$111 Million0.04% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL2.92MShares$85 Million1.54% of portfolio
-
Macquarie Group LTD Australia, C32.38MShares$69 Million0.08% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.35B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...